Entrada Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Entrada Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Entrada Therapeutics Inc
Rating: 2.35766675
Author: Trendlyne DVM scores

about

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's E...

13.99 0.43 (3.17%)

New 52W High in past week

111.7K

XNAS Volume

XNAS 17 Apr, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

16.2 / 100

Technically Bullish

78.1 / 100

1Yr Price target upside is 53%

5 analysts

Entrada Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Entrada Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's E...

New 52W High in past week

SWOT Analysis

Entrada Therapeutics Inc Live Price Chart